Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders

Justin M. Long, Debomoy Lahiri

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The central nervous system (CNS) is a remarkably complex organ system, requiring an equally complex network of molecular pathways controlling the multitude of diverse, cellular activities. Gene expression is a critical node at which regulatory control of molecular networks is implemented. As such, elucidating the various mechanisms employed in the physiological regulation of gene expression in the CNS is important both for establishing a reference for comparison to the diseased state and for expanding the set of validated drug targets available for disease intervention. MicroRNAs (miRNAs) are an abundant class of small RNA that mediates potent inhibitory effects on global gene expression. Recent advances have been made in methods employed to study the contribution of these miRNAs to gene expression. Here we review these latest advances and present a methodological workflow from the perspective of an investigator studying the physiological regulation of a gene of interest. We discuss methods for identifying putative miRNA target sites in a transcript of interest, strategies for validating predicted target sites, assays for detecting miRNA expression, and approaches for disrupting endogenous miRNA function. We consider both advantages and limitations, highlighting certain caveats that inform the suitability of a given method for a specific application. Through careful implementation of the appropriate methodologies discussed herein, we are optimistic that important discoveries related to miRNA participation in CNS physiology and dysfunction are on the horizon.

Original languageEnglish
Pages (from-to)402-418
Number of pages17
JournalExperimental Neurology
Volume235
Issue number2
DOIs
StatePublished - Jun 2012

Fingerprint

Central Nervous System Diseases
MicroRNAs
Genes
Central Nervous System
Gene Expression
Nervous System Physiological Phenomena
Workflow
Gene Expression Regulation
Research Personnel
RNA
Pharmaceutical Preparations

Keywords

  • Alzheimer
  • HITS-CLIP
  • Method
  • Non-coding RNA
  • PAR-CLIP
  • Post-transcriptional
  • Predictors
  • RIP-Chip

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience

Cite this

Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders. / Long, Justin M.; Lahiri, Debomoy.

In: Experimental Neurology, Vol. 235, No. 2, 06.2012, p. 402-418.

Research output: Contribution to journalArticle

@article{8adfc24a493545dd9140d8b94ec95172,
title = "Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders",
abstract = "The central nervous system (CNS) is a remarkably complex organ system, requiring an equally complex network of molecular pathways controlling the multitude of diverse, cellular activities. Gene expression is a critical node at which regulatory control of molecular networks is implemented. As such, elucidating the various mechanisms employed in the physiological regulation of gene expression in the CNS is important both for establishing a reference for comparison to the diseased state and for expanding the set of validated drug targets available for disease intervention. MicroRNAs (miRNAs) are an abundant class of small RNA that mediates potent inhibitory effects on global gene expression. Recent advances have been made in methods employed to study the contribution of these miRNAs to gene expression. Here we review these latest advances and present a methodological workflow from the perspective of an investigator studying the physiological regulation of a gene of interest. We discuss methods for identifying putative miRNA target sites in a transcript of interest, strategies for validating predicted target sites, assays for detecting miRNA expression, and approaches for disrupting endogenous miRNA function. We consider both advantages and limitations, highlighting certain caveats that inform the suitability of a given method for a specific application. Through careful implementation of the appropriate methodologies discussed herein, we are optimistic that important discoveries related to miRNA participation in CNS physiology and dysfunction are on the horizon.",
keywords = "Alzheimer, HITS-CLIP, Method, Non-coding RNA, PAR-CLIP, Post-transcriptional, Predictors, RIP-Chip",
author = "Long, {Justin M.} and Debomoy Lahiri",
year = "2012",
month = "6",
doi = "10.1016/j.expneurol.2011.12.043",
language = "English",
volume = "235",
pages = "402--418",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders

AU - Long, Justin M.

AU - Lahiri, Debomoy

PY - 2012/6

Y1 - 2012/6

N2 - The central nervous system (CNS) is a remarkably complex organ system, requiring an equally complex network of molecular pathways controlling the multitude of diverse, cellular activities. Gene expression is a critical node at which regulatory control of molecular networks is implemented. As such, elucidating the various mechanisms employed in the physiological regulation of gene expression in the CNS is important both for establishing a reference for comparison to the diseased state and for expanding the set of validated drug targets available for disease intervention. MicroRNAs (miRNAs) are an abundant class of small RNA that mediates potent inhibitory effects on global gene expression. Recent advances have been made in methods employed to study the contribution of these miRNAs to gene expression. Here we review these latest advances and present a methodological workflow from the perspective of an investigator studying the physiological regulation of a gene of interest. We discuss methods for identifying putative miRNA target sites in a transcript of interest, strategies for validating predicted target sites, assays for detecting miRNA expression, and approaches for disrupting endogenous miRNA function. We consider both advantages and limitations, highlighting certain caveats that inform the suitability of a given method for a specific application. Through careful implementation of the appropriate methodologies discussed herein, we are optimistic that important discoveries related to miRNA participation in CNS physiology and dysfunction are on the horizon.

AB - The central nervous system (CNS) is a remarkably complex organ system, requiring an equally complex network of molecular pathways controlling the multitude of diverse, cellular activities. Gene expression is a critical node at which regulatory control of molecular networks is implemented. As such, elucidating the various mechanisms employed in the physiological regulation of gene expression in the CNS is important both for establishing a reference for comparison to the diseased state and for expanding the set of validated drug targets available for disease intervention. MicroRNAs (miRNAs) are an abundant class of small RNA that mediates potent inhibitory effects on global gene expression. Recent advances have been made in methods employed to study the contribution of these miRNAs to gene expression. Here we review these latest advances and present a methodological workflow from the perspective of an investigator studying the physiological regulation of a gene of interest. We discuss methods for identifying putative miRNA target sites in a transcript of interest, strategies for validating predicted target sites, assays for detecting miRNA expression, and approaches for disrupting endogenous miRNA function. We consider both advantages and limitations, highlighting certain caveats that inform the suitability of a given method for a specific application. Through careful implementation of the appropriate methodologies discussed herein, we are optimistic that important discoveries related to miRNA participation in CNS physiology and dysfunction are on the horizon.

KW - Alzheimer

KW - HITS-CLIP

KW - Method

KW - Non-coding RNA

KW - PAR-CLIP

KW - Post-transcriptional

KW - Predictors

KW - RIP-Chip

UR - http://www.scopus.com/inward/record.url?scp=84860386287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860386287&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2011.12.043

DO - 10.1016/j.expneurol.2011.12.043

M3 - Article

VL - 235

SP - 402

EP - 418

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 2

ER -